Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lipocine Inc (NASDAQ:LPCN)

6.27
Delayed Data
As of Jun 28
 -0.92 / -12.80%
Today’s Change
6.17
Today|||52-Week Range
19.23
-51.51%
Year-to-Date
No recent news for Lipocine Inc.

Today’s Trading

Previous close7.19
Today’s open7.27
Day’s range6.17 - 7.36
Volume1,491,696
Average volume (3 months)235,869
Market cap$131.3M
Dividend yield--
Data as of 4:00pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)+30.63%
Earnings growth (this year)-15.12%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.12

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc+0.22+7.17%
RDHLRedhill Biopharma Lt...+0.38+3.79%
EIGREiger BioPharmaceuti...+0.27+1.48%
ARQLArQule Inc+0.04+2.25%
Data as of 4:00pm ET, 06/28/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$0.00
Annual profit (last year)-$18.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Mahesh V. Patel
CFO, Principal Accounting Officer &
EVP
Morgan R. Brown
Corporate headquarters
Salt Lake City, Utah

Forecasts

Partner Offers

Search for Jobs